Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Times Interest Earned (2016 - 2025)

Adma Biologics' Times Interest Earned history spans 13 years, with the latest figure at $38.59 for Q4 2025.

  • For Q4 2025, Times Interest Earned rose 189.92% year-over-year to $38.59; the TTM value through Dec 2025 reached $26.93, up 169.87%, while the annual FY2025 figure was $26.93, 169.87% up from the prior year.
  • Times Interest Earned reached $38.59 in Q4 2025 per ADMA's latest filing, up from $30.45 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $38.59 in Q4 2025 to a low of -$4.8 in Q2 2021.
  • Average Times Interest Earned over 5 years is $6.36, with a median of $0.64 recorded in 2023.
  • Peak YoY movement for Times Interest Earned: rose 1.97% in 2021, then surged 13899.75% in 2024.
  • A 5-year view of Times Interest Earned shows it stood at -$3.98 in 2021, then soared by 73.45% to -$1.06 in 2022, then surged by 316.84% to $2.29 in 2023, then skyrocketed by 481.25% to $13.31 in 2024, then surged by 189.92% to $38.59 in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Times Interest Earned are $38.59 (Q4 2025), $30.45 (Q3 2025), and $23.34 (Q2 2025).